Raphaël Cauchois

1.2k total citations
28 papers, 481 citations indexed

About

Raphaël Cauchois is a scholar working on Infectious Diseases, Neurology and Surgery. According to data from OpenAlex, Raphaël Cauchois has authored 28 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Neurology and 7 papers in Surgery. Recurrent topics in Raphaël Cauchois's work include COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Raphaël Cauchois is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (5 papers) and Renal Diseases and Glomerulopathies (4 papers). Raphaël Cauchois collaborates with scholars based in France, Italy and United States. Raphaël Cauchois's co-authors include Gilles Kaplanski, O. Laccourreye, Marie Koubi, Daniel Brasnu, R Jean, Pierre‐André Jarrot, Valéry Blasco, Julien Carvelli, Vanessa Pauly and H Laccourrèye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Metabolism.

In The Last Decade

Raphaël Cauchois

26 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphaël Cauchois France 10 235 137 111 93 76 28 481
István Szegedi Hungary 11 56 0.2× 52 0.4× 71 0.6× 46 0.5× 82 1.1× 52 410
Paola Muggeo Italy 12 105 0.4× 21 0.2× 40 0.4× 57 0.6× 50 0.7× 40 382
Francesco De Leonardis Italy 15 63 0.3× 66 0.5× 43 0.4× 137 1.5× 89 1.2× 32 489
Bruce A. Cook United States 11 58 0.2× 81 0.6× 49 0.4× 94 1.0× 73 1.0× 16 438
R Jean France 10 145 0.6× 89 0.6× 77 0.7× 59 0.6× 63 0.8× 46 408
Amir Emamifar Denmark 11 45 0.2× 21 0.2× 30 0.3× 46 0.5× 99 1.3× 36 632
Ioannis Boletis Greece 15 74 0.3× 42 0.3× 126 1.1× 69 0.7× 133 1.8× 61 632
J Cabane France 8 45 0.2× 38 0.3× 37 0.3× 56 0.6× 103 1.4× 16 363
Hasan Satış Türkiye 12 98 0.4× 52 0.4× 292 2.6× 91 1.0× 65 0.9× 50 482
Pirabu Sakthivel India 13 66 0.3× 62 0.5× 65 0.6× 236 2.5× 143 1.9× 69 475

Countries citing papers authored by Raphaël Cauchois

Since Specialization
Citations

This map shows the geographic impact of Raphaël Cauchois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Cauchois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Cauchois more than expected).

Fields of papers citing papers by Raphaël Cauchois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Cauchois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Cauchois. The network helps show where Raphaël Cauchois may publish in the future.

Co-authorship network of co-authors of Raphaël Cauchois

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Cauchois. A scholar is included among the top collaborators of Raphaël Cauchois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Cauchois. Raphaël Cauchois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varoquaux, A., K. Mazodier, R. Müller, et al.. (2025). Long-term tocilizumab therapy in patients with corticosteroid-resistant active moderate-to-severe thyroid eye disease. European Journal of Endocrinology. 193(5). 613–621.
2.
Cauchois, Raphaël, R. Müller, Aurélie S. Leroyer, et al.. (2024). Vascular endothelial-cadherin is involved in endothelial cell detachment during thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 22(10). 2879–2888. 1 indexed citations
3.
Müller, R., Raphaël Cauchois, Samantha Fernandez, et al.. (2024). Reduction of mortality, cardiac damage, and cerebral damage by IL-1 inhibition in a murine model of TTP. Blood. 143(26). 2791–2803. 1 indexed citations
4.
Cauchois, Raphaël, et al.. (2023). Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?. Journal of Clinical Medicine. 12(3). 758–758. 9 indexed citations
5.
Cauchois, Raphaël, Pierre Suchon, R Jean, et al.. (2022). Factors associated with dexamethasone efficacy in COVID‐19. A retrospective investigative cohort study. Journal of Medical Virology. 94(7). 3169–3175. 2 indexed citations
6.
Tellier, Edwige, Raphaël Cauchois, Julien Faccini, et al.. (2022). Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity. Haematologica. 108(4). 1127–1140. 8 indexed citations
7.
Guervilly, Christophe, Stéphane Burtey, Florence Sabatier, et al.. (2021). Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Advances. 5(3). 628–634. 109 indexed citations
8.
Cauchois, Raphaël, Marie Koubi, Pierre‐André Jarrot, et al.. (2021). Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue. Annals of Hematology. 100(11). 2799–2803. 13 indexed citations
9.
Giorgi, Roch, Marie Koubi, Raphaël Cauchois, et al.. (2021). Excess body weight is an independent risk factor for severe forms of COVID-19. Metabolism. 117. 154703–154703. 26 indexed citations
10.
Cauchois, Raphaël, Marie Koubi, Julien Carvelli, et al.. (2020). Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Proceedings of the National Academy of Sciences. 117(32). 18951–18953. 150 indexed citations
11.
Kaplanski, Gilles, Pierre Esnault, Valéry Blasco, et al.. (2020). Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.. Autoimmunity Reviews. 20(2). 102726–102726. 16 indexed citations
12.
Jarrot, Pierre‐André, Jean Roudier, Raphaël Cauchois, et al.. (2020). Axial Articular Manifestations in Primary Sjögren Syndrome: Association With Spondyloarthritis. The Journal of Rheumatology. 48(7). 1037–1046. 3 indexed citations
13.
Gorphe, Philippe, et al.. (2011). [Unilateral laryngeal paralysis after intra capsular loboisthmectomy without laryngeal nerve dissection].. PubMed. 132(1). 45–9. 2 indexed citations
14.
Laccourreye, Laurent, A. Werner, Raphaël Cauchois, & O. Laccourreye. (2009). Interprétation et mémorisation de l’information pour parotidectomie. Annales d Otolaryngologie et de Chirurgie Cervico-Faciale. 126(2). 53–60. 5 indexed citations
15.
Trévidic, Patrick, et al.. (2009). Anatomie faciale et toxine botulique : les balances musculaires. Annales de Dermatologie et de Vénéréologie. 136. S61–S66. 2 indexed citations
17.
Laccourreye, O., Raphaël Cauchois, M. Ménard, et al.. (2005). Fermeture cutanée par colle à base d'octylcyanoacrylate (Dermabond®) en chirurgie cervicofaciale programmée : étude longitudinale prospective. Annales de Chirurgie. 130(10). 624–630. 19 indexed citations
18.
Laccourreye, O., et al.. (1996). [Surgery of primary malignant melanomas of the mucosa of the nasal fossa and facial sinuses].. PubMed. 113(3). 163–9. 4 indexed citations
19.
Laccourreye, O., et al.. (1995). [Dysfunction of the facial nerve following total conservative parotidectomy for pleomorphic adenoma].. PubMed. 112(1-2). 63–8. 12 indexed citations
20.
Laccourreye, O., et al.. (1993). Cricohyoidopexy in Selected Infrahyoid Epiglottic Carcinomas Presenting With Pathological Preepiglottic Space Invasion. Archives of Otolaryngology - Head and Neck Surgery. 119(8). 881–886. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026